Short-Term Quality of Life Outcomes: A Comparative Analysis of Thulium Laser Vaporization (ThuVap) vs. Transurethral Resection of the Prostate (TURP)
Open Access
- 16 January 2025
- journal article
- Published by Science Publishing Group in International Journal of Clinical Urology
- Vol. 9 (1) , 13-19
Abstract
Objective: This study aimed to compare short-term quality of life (QOL) outcomes and perioperative parameters between transurethral resection of the prostate (TURP) and thulium laser vaporization of the prostate (ThuVap) in patients with benign prostatic hyperplasia (BPH). Materials and Methods: A retrospective analysis was conducted on 106 patients with BPH who underwent either TURP (n = 58) or ThuVap (n = 48) at our institution between April 2021 and August 2024. Preoperative and postoperative evaluations included the International Prostate Symptom Score (I-PSS), Overactive Bladder Symptom Score (OABSS), QOL index, and uroflowmetry. Perioperative outcomes, including operative time, catheterization duration, and hemoglobin (Hb) reduction, were also analyzed. Results: Both TURP and ThuVap showed sustained improvements in I-PSS, OABSS, and QOL index during the 3-month follow-up period, with no significant differences between the groups. ThuVap demonstrated a significantly lower rate of Hb reduction on the first postoperative day compared to TURP (5.9% vs. 8.5%, P < 0.05), likely due to reduced intraoperative bleeding. Although ThuVap had a shorter mean operative time (82.3 vs. 99.3 minutes), this difference was not statistically significant (P = 0.1). Discussion: The findings indicate that both TURP and ThuVap effectively improve postoperative QOL. ThuVap's reduced bleeding may provide advantages in patients with higher cardiovascular or bleeding risks. However, variations in operative time between studies may be influenced by factors such as surgeons' experience and institutional protocols. Conclusion: Both TURP and ThuVap are effective surgical options for improving QOL in BPH patients. However, surgical efficiency and outcomes may be influenced by the surgeon's expertise and the preoperative condition of the patients. ThuVap offers additional benefits of reduced intraoperative bleeding, which may support its use in selected cases.Keywords
This publication has 18 references indexed in Scilit:
- Assessing the Learning Curve of Holmium Laser Enucleation of Prostate (HoLEP). A Systematic ReviewUrology, 2018
- Thulium (Tm:YAG) laser vaporesection of prostate and bipolar transurethral resection of prostate in patients with benign prostate hyperplasia: a systematic review and meta-analysisLasers in Medical Science, 2018
- Bipolar, Monopolar, Photovaporization of the Prostate, or Holmium Laser Enucleation of the ProstateUrologic Clinics of North America, 2016
- Photoselective vaporization of the prostate with GreenLight 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis of randomized controlled trialsLasers in Medical Science, 2015
- A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An UpdateEuropean Urology, 2015
- Long-Term Effects of Doxazosin, Finasteride and Combination Therapy on Quality of Life in Men with Benign Prostatic HyperplasiaJournal of Urology, 2013
- Benign Prostatic Hyperplasia: Current Clinical PracticePrimary Care: Clinics in Office Practice, 2010
- Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostateNeurourology and Urodynamics, 2008
- EAU 2004 Guidelines on Assessment, Therapy and Follow-Up of Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction (BPH Guidelines)European Urology, 2004
- The Development of Human Benign Prostatic Hyperplasia with AgeJournal of Urology, 1984